HBK Investments’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-760,772
Closed -$7.47M 247
2022
Q3
$7.47M Hold
760,772
0.05% 117
2022
Q2
$7.44M Buy
760,772
+10,772
+1% +$105K 0.04% 140
2022
Q1
$7.32M Hold
750,000
0.03% 178
2021
Q4
$7.31M Hold
750,000
0.03% 182
2021
Q3
$7.28M Hold
750,000
0.03% 188
2021
Q2
$7.3M Buy
+750,000
New +$7.34M 0.03% 193

Other funds holding AONC

HBK Investments's AONC Position: Q4 2022 in Review

HBK Investments sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q4 2022, closing a stake of 760,772 shares — an estimated $7.47M sold.

HBK Investments first reported a position in AONC in Q2 2021 and held it in 6 quarters. The position peaked at $7.47M in Q3 2022. 79 funds tracked by Wall St. Rank hold AONC as of Q4 2022.

  • HBK Investments reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • HBK Investments sold 760,772 American Oncology Network, Inc. Class A Common Stock shares in Q4 2022, an estimated $7.47M.
  • HBK Investments first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • HBK Investments's American Oncology Network, Inc. Class A Common Stock position peaked at $7.47M in Q3 2022.
  • 79 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q4 2022.

Based on HBK Investments's 13F filing for Q4 2022, filed 14 Feb 2023.